Efficacy of an Experimental Azithromycin Cream for Prophylaxis of Tick-Transmitted Lyme Disease Spirochete Infection in a Murine Model
Open Access
- 1 January 2014
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 58 (1) , 348-351
Abstract
As an alternative to oral prophylaxis for the prevention of tick transmission ofBorrelia burgdorferi, we tested antibiotic cream prophylactic formulations in a murine model of spirochete infection. A 4% preparation of doxycycline cream afforded no protection, but a single application of 4% azithromycin cream was 100% protective when applied directly to the tick bite site at the time of tick removal. Indeed, the azithromycin cream was 100% effective when applied at up to 3 days after tick removal and protected 74% of mice exposed to tick bite when applied at up to 2 weeks after tick removal. Azithromycin cream was also protective when applied at a site distal to the tick bite site, suggesting that it was having a systemic effect in addition to a local transdermal effect. Mice that were protected from tick-transmitted infection did not seroconvert and did not infect larval ticks on xenodiagnosis. Azithromycin cream formulations appear to hold promise for Lyme disease prophylaxis.Keywords
This publication has 30 references indexed in Scilit:
- Human Risk of Infection with Borrelia burgdorferi, the Lyme Disease Agent, in Eastern United StatesThe American Journal of Tropical Medicine and Hygiene, 2012
- Elimination of Borrelia burgdorferi and Anaplasma phagocytophilum in Rodent Reservoirs and Ixodes scapularis Ticks Using a Doxycycline Hyclate-Laden BaitThe American Journal of Tropical Medicine and Hygiene, 2011
- Failure of Topical Antibiotics to Prevent Disseminated Borrelia burgdorferi Infection Following a Tick Bite in C3H/HeJ MiceThe Journal of Infectious Diseases, 2011
- Evaluation of the preventive capacities of a topically applied azithromycin formulation against Lyme borreliosis in a murine modelJournal of Antimicrobial Chemotherapy, 2011
- Vaccines against Lyme Disease: What Happened and What Lessons Can We Learn?Clinical Infectious Diseases, 2011
- The Lyme Disease Vaccine—A Public Health PerspectiveClinical Infectious Diseases, 2011
- A sustained-release formulation of doxycycline hyclate (Atridox) prevents simultaneous infection of Anaplasma phagocytophilum and Borrelia burgdorferi transmitted by tick biteJournal of Medical Microbiology, 2008
- A Controlled Trial of a Novel Primary Prevention Program for Lyme Disease and Other Tick-Borne IllnessesHealth Education & Behavior, 2007
- Sustained-Release Formulation of Doxycycline Hyclate for Prophylaxis of Tick Bite Infection in a Murine Model of Lyme BorreliosisAntimicrobial Agents and Chemotherapy, 2004
- Topical Prophylaxis for Lyme Disease after Tick Bite in a Rodent ModelThe Journal of Infectious Diseases, 1993